These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 2004546)

  • 21. Fenbufen and indomethacin in the treatment of rheumatoid arthritis. A comparative double-blind, crossover study.
    Ammitzbøll F
    Scand J Rheumatol Suppl; 1979; (23):5-10. PubMed ID: 373083
    [No Abstract]   [Full Text] [Related]  

  • 22. [Clinical profile of acemetacin].
    Rechziegler H; Thebud-Lassak R
    Med Klin (Munich); 1990 May; 85(5):340-6, 352. PubMed ID: 2192250
    [No Abstract]   [Full Text] [Related]  

  • 23. [Treatment of osteoarthritis of the knee joint. Efficacy and tolerance to acemetacin slow release in comparison to celecoxib].
    Leeb BF; Bucsi L; Keszthelyi B; Böhmova J; Valesova M; Hawel R; Mayrhofer F; Singer F; Aglas F; Bröll H
    Orthopade; 2004 Sep; 33(9):1032-41. PubMed ID: 15156311
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Comparative evaluation of the therapeutic action and tolerance of diftalone and indomethacin in the long-term treatment of rheumatoid arthritis].
    Altucci P; Gattoni A; Leonessa V
    Minerva Med; 1976 Mar; 67(12):717-24. PubMed ID: 1256690
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A crossover clinical trial of piroxicam, indomethacin and ibuprofen in rheumatoid arthritis.
    Balogh Z; Papazoglou SN; MacLeod M; Buchanan WW
    Curr Med Res Opin; 1979; 6(2):148-53. PubMed ID: 380913
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A comparative study of flurbiprofen and indomethacin in rheumatoid arthritis.
    Brewis ID
    Curr Med Res Opin; 1977; 5(1):48-52. PubMed ID: 334474
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acemetacin-induced fixed drug eruption.
    Cebeci F; Yaşar Ş; Aytekin S; Güneş P
    Indian J Pharmacol; 2016; 48(2):219-20. PubMed ID: 27114641
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Changes in the serum pepsinogen level during therapy with acemtacin retard as a measure of gastroduodenal tolerance].
    Kullich W; Klein G
    Wien Med Wochenschr; 1991; 141(15):331-5. PubMed ID: 1949833
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clinical results of a double blind study with the new antirheumatic agent acemetacin (author's transl)].
    Kronhagel R
    Arzneimittelforschung; 1980; 30(8A):1445-8. PubMed ID: 7191314
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Results of a double-blind study with indomethacin and indoprofen, a new non-steroidal antirheumatic agent.
    Seigmund H; Schneider B
    Eur J Rheumatol Inflamm; 1981; 4(1):79-86. PubMed ID: 7042366
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A double-blind trial comparing indomethacin sustained release capsules (Indocid-R) with indomethacin capsules in patients with rheumatoid arthritis.
    Rhymer AR; Hart CB; Daurio C
    Rheumatol Rehabil; 1982 May; 21(2):101-6. PubMed ID: 7043710
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mechanisms underlying the anti-inflammatory activity and gastric safety of acemetacin.
    Chávez-Piña AE; McKnight W; Dicay M; Castañeda-Hernández G; Wallace JL
    Br J Pharmacol; 2007 Nov; 152(6):930-8. PubMed ID: 17876306
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lack of influence of body mass index on efficacy and tolerance of acemetacin in short-term treatment of musculoskeletal diseases.
    Dejaco C; Duftner C; Schirmer M
    Rheumatol Int; 2007 Feb; 27(4):351-5. PubMed ID: 16957886
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Double-blind crossover comparison of piroxicam and indomethacin in rheumatoid arthritis.
    Domljan Z; Durrigl T
    Eur J Rheumatol Inflamm; 1983; 6(3):291-6. PubMed ID: 6391934
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Controlled trials of acemetacin versus piroxicam in osteoarthritis.
    Kronhagel R
    Br J Clin Pract; 1986 Nov; 40(11):472-7. PubMed ID: 3307860
    [No Abstract]   [Full Text] [Related]  

  • 36. [The influence of acemetacin and indometacin on gastrointestinal blood loss in normal volunteers and rheumatic patients (author's transl)].
    Uthgenannt H; Mohing W; Köhler G; Schmidt F; Havemann R
    Arzneimittelforschung; 1980; 30(8A):1424-7. PubMed ID: 6968220
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative evaluation of carprofen and indomethacin in rheumatoid patients.
    Lussier A; Rouleau L; Caron M; Tétreault L
    Int J Clin Pharmacol Ther Toxicol; 1980 Nov; 18(11):482-7. PubMed ID: 7009441
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lack of effects of acemetacin on signalling pathways for leukocyte adherence may explain its gastrointestinal safety.
    Chávez-Piña AE; Vong L; McKnight W; Dicay M; Zanardo RC; Ortiz MI; Castañeda-Hernández G; Wallace JL
    Br J Pharmacol; 2008 Nov; 155(6):857-64. PubMed ID: 18695646
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Double-blind multicentre, between patients comparison of indoprofen and indomethacin in rheumatoid arthritis patients under basic steroid treatment.
    del Campo JB
    Eur J Rheumatol Inflamm; 1981; 4(1):135-43. PubMed ID: 7042357
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A double blind crossover study of carprofen and indomethacin in patients with rheumatoid arthritis.
    Jalava S
    Scand J Rheumatol Suppl; 1983; 48():5-9. PubMed ID: 6340183
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.